Open in Screener

ROIV

Roivant Sciences Ltd

Sep 17 • 04:00PM ET

15.28

+1.10 7.76 %

Healthcare • Biotechnology • United Kingdom • NASD

Peers: VRTX REGN BIIB BMRN ALNY CRSP INCY NBIX IONS EDIT

| Held by: IJH VTI VB XBI VBK VXF MDY IBB IJK SPMD

Index	-	P/E	-	EPS (ttm)	-0.70	Insider Own	36.78%	Shs Outstand	682.23M	Perf Week	10.97%
Market Cap	10.43B	Forward P/E	-	EPS next Y	-1.41	Insider Trans	-2.64%	Shs Float	431.75M	Perf Month	29.38%
Enterprise Value	6.50B	PEG	-	EPS next Q	-0.32	Inst Own	64.12%	Short Float	9.04%	Perf Quarter	37.53%
Income	-490.63M	P/S	449.18	EPS this Y	-427.24%	Inst Trans	-8.90%	Short Ratio	6.15	Perf Half Y	42.67%
Sales	23.23M	P/B	2.40	EPS next Y	-11.74%	ROA	-13.44%	Short Interest	39.05M	Perf YTD	29.16%
Book/sh	6.37	P/C	2.32	EPS next 5Y	-	ROE	-15.84%	52W High	14.48 5.56%	Perf Year	27.97%
Cash/sh	6.60	P/FCF	-	EPS past 3/5Y	42.73% -99.51%	ROIC	-11.06%	52W Low	8.73 75.03%	Perf 3Y	300.00%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-19.30% -	Gross Margin	96.33%	Volatility	3.59% 3.07%	Perf 5Y	-
Dividend TTM	-	EV/Sales	279.77	EPS Y/Y TTM	-111.82%	Oper. Margin	-5104.73%	ATR (14)	0.50	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	40.54	Sales Y/Y TTM	-85.32%	Profit Margin	-2111.79%	RSI (14)	82.00	Recom	1.17
Dividend Gr. 3/5Y	- -	Current Ratio	40.54	EPS Q/Q	-369.32%	SMA20	18.76%	Beta	1.17	Target Price	18.40
Payout	-	Debt/Eq	0.02	Sales Q/Q	-96.06%	SMA50	26.71%	Rel Volume	4.24	Prev Close	14.18
Employees	750	LT Debt/Eq	0.02	Earnings	Aug 11 BMO	SMA200	35.52%	Avg Volume	6.35M	Price	15.28
IPO	Dec 08, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	-0.84% -70.28%	Trades		Volume	26,928,069	Change	7.76%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-02-25	Initiated	Citigroup	Buy	$16
Jul-10-25	Resumed	Goldman	Buy	$19
Feb-15-24	Initiated	Wolfe Research	Outperform	$17
Jan-05-24	Initiated	Piper Sandler	Overweight	$20
Dec-12-23	Initiated	Deutsche Bank	Buy	$14
Oct-17-23	Initiated	Guggenheim	Buy	$17
Jun-08-23	Initiated	BofA Securities	Neutral	$10.50
Oct-27-22	Initiated	JP Morgan	Overweight	$7
May-23-22	Initiated	SVB Leerink	Outperform	$6
Apr-29-22	Initiated	Cantor Fitzgerald	Overweight	$15
Dec-15-21	Initiated	Goldman	Buy	$15
Nov-08-21	Initiated	H.C. Wainwright	Buy	$14
Oct-28-21	Initiated	Citigroup	Buy	$11
Oct-26-21	Initiated	Truist	Buy	$15
Oct-26-21	Initiated	Jefferies	Buy	$10
Oct-26-21	Initiated	Cowen	Outperform

Show Previous Ratings

Today 04:09PM	Roivant Flirts With A Profit-Taking Zone, Stoked By Promise In Autoimmune Disease (Investor's Business Daily) +7.76%
12:49PM	Why Roivant Sciences Stock Is Soaring Today (Motley Fool)
10:05AM	Roivant Leaps Into A Profit-Taking Zone, Stoked By Promise In Autoimmune Disease (Investor's Business Daily)
07:00AM	Roivant and Priovant Announce Positive Phase 3 VALOR Study Results for Brepocitinib in 52-Week Placebo-Controlled Trial in Dermatomyositis (DM) (GlobeNewswire)
Sep-14-25 04:00AM	Vivek Ramaswamy Sells $22.7 Million of Roivant Sciences Stock (Barrons.com)
04:30PM	Loading…
Sep-11-25 04:30PM	Roivant Named on Fortune Media and Great Place To Work's 2025 Best Workplaces in BioPharma List (GlobeNewswire)
11:11AM	Roivant Sciences Ltd. (ROIV) Wins Orphan Drug Status in Japan for Mosliciguat (Insider Monkey)
Sep-03-25 01:01PM	Roivant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves' Disease Patients (GlobeNewswire)
Aug-28-25 11:49PM	Roivant Sciences (ROIV) Announces Q1 2025 Business Update (Insider Monkey)
Aug-12-25 06:42PM	Why Roivant Sciences Stock Bounced Back on Tuesday (Motley Fool)
03:02AM	Roivant Sciences Ltd (ROIV) Q1 2025 Earnings Call Highlights: Strong Cash Position and ... (GuruFocus.com)
Aug-11-25 04:58PM	Why Roivant Sciences Stock Was Slipping on Monday (Motley Fool)
08:15AM	Roivant Sciences Ltd. (ROIV) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
07:00AM	Roivant Reports Financial Results for the First Quarter Ended June 30, 2025, and Provides Business Update (GlobeNewswire)
Aug-08-25 09:17AM	What To Expect From Roivant Sciences Ltd (ROIV) Q1 2026 Earnings (GuruFocus.com)
06:15PM	Loading…
Aug-07-25 06:15PM	Kura Oncology (KURA) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
Aug-05-25 08:10AM	Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
Jul-28-25 04:05PM	Roivant to Report Financial Results for the First Quarter Ended June 30, 2025, and Provide Business Update on Monday, August 11, 2025 (GlobeNewswire)
Jul-24-25 11:47PM	Goldman Sachs Resumes Roivant Sciences (ROIV) Coverage with 'Buy' Rating (Insider Monkey)
Jul-11-25 06:20AM	Should Invesco S&P MidCap 400 GARP ETF (GRPM) Be on Your Investing Radar? (Zacks)
Jun-24-25 12:45PM	Roivant Sciences Subsidiary Pulmovant Publishes Positive Phase 1 Data for Inhaled PH Treatment Mosliciguat (Insider Monkey)
Jun-16-25 07:00AM	Pulmovant Announces Publication of Pharmacokinetics and Lung Deposition Data for Inhaled Mosliciguat in Clinical Pharmacokinetics (GlobeNewswire)
Jun-09-25 04:05PM	Roivant and Priovant to Host Investor Video Conference at 1:00 PM ET on Tuesday, June 17 on Brepocitinib and the Unmet Medical Need in Dermatomyositis (GlobeNewswire)
May-29-25 08:15AM	Roivant Sciences Ltd. (ROIV) Reports Q4 Loss, Lags Revenue Estimates (Zacks) +6.40%
07:00AM	Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2025, and Provides Business Update (GlobeNewswire)
May-28-25 02:17PM	H.C. Wainwright Keeps Buy Rating on Roivant Sciences (ROIV) Stock (Insider Monkey)
09:15AM	What To Expect From Roivant Sciences Ltd (ROIV) Q4 2025 Earnings (GuruFocus.com)
May-15-25 05:15PM	Gossamer Bio (GOSS) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:10PM	Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2025 and Provide Business Update on Thursday, May 29, 2025 (GlobeNewswire)
May-14-25 05:40PM	Codexis (CDXS) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
05:10PM	Loading…
May-13-25 05:10PM	Spero Therapeutics, Inc. (SPRO) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
May-08-25 07:45AM	Liquidia Technologies, Inc. (LQDA) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
May-06-25 06:20AM	Should Invesco S&P MidCap 400 Pure Growth ETF (RFG) Be on Your Investing Radar? (Zacks)
May-02-25 10:37AM	Roivant Sciences Ltd. (ROIV): Among David Einhorn's Stock Picks with Huge Upside Potential (Insider Monkey)
Apr-29-25 11:35AM	Roivant Sciences Ltd. (ROIV): Among Billionaire Andreas Halvorsen's Stock Picks With Huge Upside Potential (Insider Monkey)
Apr-23-25 12:13PM	Roivant Sciences: Primed For Growth With A De-Risked Pipeline (Seeking Alpha)
Apr-21-25 04:08PM	Immunovant Dives On Its C-Suite Sweep, Narrowed Plans For Leading Drug (Investor's Business Daily)
10:18AM	Immunovant Crumbles After Roivant Sweeps Out Its C-Suite, Unveils Strategic Shift (Investor's Business Daily)
07:00AM	Immunovant Announces Next Phase of Growth with Roivant Including Changes to its Leadership Team and Additional Indications Sjogren's Disease (SjD) and Cutaneous Lupus Erythematosus (CLE) for IMVT-1402 (GlobeNewswire)
07:00AM	Immunovant Announces Next Phase of Growth with Roivant Including Changes to its Leadership Team and Additional Indications Sj gren's Disease (SjD) and Cutaneous Lupus Erythematosus (CLE) for IMVT-1402 (GlobeNewswire)
Apr-14-25 06:20AM	Is Invesco S&P MidCap 400 Pure Growth ETF (RFG) a Strong ETF Right Now? (Zacks)
Apr-11-25 03:07PM	Is Roivant Sciences Ltd. (ROIV) the Top Healthcare Stock to Buy According to Billionaire David Einhorn? (Insider Monkey)
10:04AM	Certara (CERT) Soars 8.0%: Is Further Upside Left in the Stock? (Zacks)
Apr-10-25 05:08PM	Roivant Sciences Ltd. (ROIV): Among the Best Low Priced Growth Stocks to Invest In (Insider Monkey)
Mar-31-25 04:03PM	Impax Small Cap Fund Q4 2024 Commentary (Seeking Alpha)
Mar-29-25 04:00PM	Is Roivant Sciences (ROIV) the Best Mid Cap Biotech Stock to Buy? (Insider Monkey)
Mar-25-25 02:12PM	Is Roivant Sciences Ltd. (NASDAQ:ROIV) One of The Best Stocks to Buy According to Billionaire David Einhorn? (InsiderMonkey)
Mar-19-25 04:04PM	Roivant And Immunovant Won't Seek Approval Despite Phase 3 Win. Why Shares Rose. (Investor's Business Daily)
09:26AM	Roivant, Immunovant Succeed In Phase 3. But There's A Twist And Shares Tumbled. (Investor's Business Daily)
07:45AM	Roivant Announces Positive Results for Batoclimab Myasthenia Gravis (MG) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Studies (GlobeNewswire)
Mar-18-25 04:32PM	Roivant to Host Investor Webcast at 8:00 AM ET on Wednesday, March 19 to Review Results from Batoclimab Myasthenia Gravis (MG) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Programs (GlobeNewswire)
Mar-03-25 09:15AM	Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna (GlobeNewswire) -5.31%
Feb-25-25 08:00AM	Early Warning Report Issued Pursuant to National Instrument 62 103: Roivant announces Resignation and Replacement of Arbutus Board (GlobeNewswire)
Feb-12-25 10:00AM	Roivant Sciences price target lowered to $12 from $13 at BofA (TipRanks)
Feb-10-25 07:00AM	Roivant Reports Financial Results for the Third Quarter Ended December 31, 2024, and Provides Business Update (GlobeNewswire)
Feb-07-25 07:06AM	What To Expect From Roivant Sciences Ltd (ROIV) Q3 2025 Earnings (GuruFocus.com)
Feb-03-25 07:00AM	Zest Health Announces $13M in Funding to Curb Unnecessary Pharmaceutical Spend through High-Touch Care (GlobeNewswire)
Jan-29-25 04:05PM	Roivant to Report Financial Results for the Third Quarter Ended December 31, 2024 and Provide Business Update on Monday, February 10, 2025 (GlobeNewswire)
Jan-15-25 08:49PM	Vivek Ramaswamy Open to Replacing JD Vance in Senateif Offered (The Wall Street Journal)
Jan-12-25 09:40AM	Is Roivant Sciences (ROIV) the Best Medical Stock to Buy Under $20? (Insider Monkey)
Jan-02-25 03:28AM	Why Roivant Sciences Ltd. (ROIV) Is Skyrocketing (Insider Monkey)
Dec-03-24 07:00AM	Roivant Announces Topline Results from Phase 2 RESOLVE-Lung Study of Namilumab in Chronic Active Pulmonary Sarcoidosis (GlobeNewswire)
07:00AM	Kinevant Sciences Announces Topline Results from Phase 2 RESOLVE-Lung Study of Namilumab in Chronic Active Pulmonary Sarcoidosis (GlobeNewswire)
Nov-15-24 05:01PM	Vivek Ramaswamy's Net Worth Is 9 Figures See How the DOGE Co-Lead Made His Millions (Investopedia)
Nov-12-24 07:00AM	Roivant Reports Financial Results for the Second Quarter Ended September 30, 2024, and Provides Business Update (GlobeNewswire)
Nov-11-24 07:04AM	Roivant Sciences Ltd (ROIV) Q2 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Oct-29-24 04:35PM	Roivant to Report Financial Results for the Second Quarter Ended September 30, 2024 and Provide Business Update on Tuesday, November 12, 2024 (GlobeNewswire)
Oct-28-24 09:25AM	Organon Completes Acquisition of Dermavant, including Innovative Dermatologic Therapy, VTAMA (tapinarof) Cream, 1% (GlobeNewswire)
Sep-18-24 07:30AM	Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA (tapinarof) Cream, 1% (GlobeNewswire)
Sep-10-24 06:30AM	Roivant Unveils New Pipeline Program Mosliciguat, A Potential First-In-Class and Best-In-Category Inhaled Once-Daily Soluble Guanylate Cyclase (sGC) Activator (GlobeNewswire)
06:30AM	Pulmovant presents positive proof-of-concept data from the Phase 1b ATMOS study of Mosliciguat in Pulmonary Hypertension at European Respiratory Society Congress (GlobeNewswire)
Sep-09-24 07:00AM	Roivant Provides Update on Graves' Disease Development Program (GlobeNewswire)
Sep-04-24 06:55PM	The Federal Reserve should refresh its mandate: Former presidential candidate Vivek Ramaswamy (Yahoo Finance)
Aug-08-24 07:00AM	Roivant Reports Financial Results for the First Quarter Ended June 30, 2024, and Provides Business Update (GlobeNewswire) +6.69%
Jul-25-24 04:05PM	Roivant to Report Financial Results for the First Quarter Ended June 30, 2024, and Provide Business Update on Thursday, August 8, 2024 (GlobeNewswire)
May-31-24 08:04AM	Roivant Sciences Ltd. (NASDAQ:ROIV) Q4 2023 Earnings Call Transcript (Insider Monkey)
May-30-24 11:53AM	ROIV Stock Earnings: Roivant Sciences Beats EPS, Misses Revenue for Q4 2024 (InvestorPlace)
08:20AM	Roivant Sciences Ltd. (ROIV) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
07:00AM	Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024, and Provides Business Update (GlobeNewswire)
May-27-24 06:28PM	Institutional Investors are Betting on Roivant Sciences (NASDAQ:ROIV) (Insider Monkey)
06:13PM	7 Best Mid-Cap Healthcare Stocks To Buy Now (Insider Monkey)
May-16-24 04:05PM	Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024, and Provide Business Update on Thursday, May 30, 2024 (GlobeNewswire)
May-08-24 02:43AM	Greenlight Capital Initiated a Position in Roivant Sciences (ROIV) in Q1 (Insider Monkey)
May-07-24 02:04PM	Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare (InvestorPlace)
May-01-24 10:47AM	3 Healthcare Stocks With the Potential to Triple Your Investment by 2026 (InvestorPlace)
Apr-25-24 08:00AM	Roivant and Kinevant Sciences Complete Enrollment in RESOLVE-Lung, a Phase 2 Study Evaluating Namilumab for Chronic Pulmonary Sarcoidosis (Business Wire)
Apr-12-24 11:09AM	10 Most Undervalued Stocks to Buy for Under $20 (Insider Monkey)
Apr-02-24 07:00AM	Roivant Announces Positive NEPTUNE Study Results for Brepocitinib in NIU, as well as Board Authorization for up to $1.5 Billion Share Repurchase Program, Including Repurchase of Entire Sumitomo Pharma Stake for $648 Million (GlobeNewswire)
Mar-27-24 01:55PM	Stocks to Watch Wednesday: Carnival, Robinhood, Trump Media, Merck (The Wall Street Journal) +7.54%
Mar-26-24 06:22PM	Roivant Sciences Set to Join S&P MidCap 400; Sunrun to Join S&P SmallCap 600 (PR Newswire)
Mar-17-24 08:50AM	30 Biggest Biotechnology Companies in the World (Insider Monkey)
Mar-14-24 07:04AM	10 Stocks George Soros and Insiders Are Crazy About (Insider Monkey)
Feb-15-24 02:45AM	Do You Think the Management of Roivant Sciences (ROIV) Can Create Value? (Insider Monkey)
Feb-13-24 07:00AM	Roivant Reports Financial Results for the Third Quarter Ended December 31, 2023, and Provides Business Update (GlobeNewswire)
Feb-10-24 02:55AM	Roivant Sciences Ltd President & COO Eric Venker Sells 96,950 Shares (GuruFocus.com)
Jan-30-24 04:05PM	Roivant to Report Financial Results for the Third Quarter Ended December 31, 2023, and Provide Business Update on Tuesday, February 13, 2024 (GlobeNewswire)
Dec-27-23 08:05PM	5 High Growth International Stocks to Buy (Insider Monkey)
Dec-20-23 04:30PM	Roivant Reports Positive Initial Phase 2 Results for Batoclimab in Graves' Disease (GlobeNewswire) -7.78% +5.82%
Dec-14-23 09:00AM	Roche Completes Acquisition of Telavant from Roivant, Including Rights to Novel TL1A Directed Antibody (RVT-3101) for the Treatment of Inflammatory Bowel Disease (GlobeNewswire)
Nov-28-23 07:00AM	Roivant Announces Positive IMVT-1402 Initial 600 mg MAD Results that Confirm Best-in-Class Potential (GlobeNewswire)

Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. Its product portfolio includes Vtama, Batoclimab, Brepocitinib, Namilumab, and RVT-2001, which aims to treat psoriasis, atopic dermatitis, thyroid eye disease, and other illnesses. The company was founded by Vivek Ramaswamy on April 7, 2014 and is headquartered in London, the United Kingdom.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Ramaswamy Vivek	10% Owner	Sep 03 '25	Sale	12.50	1,195,000	14,937,500	36,089,108	Sep 05 05:01 PM
Ramaswamy Vivek	10% Owner	Sep 05 '25	Sale	12.96	385,816	5,000,175	35,508,359	Sep 05 05:01 PM
Ramaswamy Vivek	10% Owner	Sep 04 '25	Sale	12.92	194,933	2,518,534	35,894,175	Sep 05 05:01 PM
Venker Eric	President & Immunovant CEO	Aug 20 '25	Option Exercise	3.85	100,000	385,000	1,753,585	Aug 22 09:00 PM
Venker Eric	President & Immunovant CEO	Aug 20 '25	Sale	11.72	100,000	1,172,000	1,653,585	Aug 22 09:00 PM
Venker Eric	Officer	Aug 20 '25	Proposed Sale	11.72	100,000	1,172,120		Aug 20 04:30 PM
Venker Eric	President & Immunovant CEO	Jul 21 '25	Option Exercise	3.85	100,000	385,000	1,562,223	Jul 23 09:00 PM
Venker Eric	President & Immunovant CEO	Jul 21 '25	Sale	11.52	100,000	1,152,000	1,462,223	Jul 23 09:00 PM
Venker Eric	Officer	Jul 21 '25	Proposed Sale	11.52	100,000	1,151,942		Jul 21 04:34 PM
Venker Eric	President & COO	Jun 20 '25	Option Exercise	3.85	100,000	385,000	1,562,223	Jun 24 09:01 PM
Venker Eric	President & COO	Jun 20 '25	Sale	11.45	100,000	1,145,000	1,462,223	Jun 24 09:01 PM
Ramaswamy Vivek	10% Owner	Jun 20 '25	Sale	11.46	577,007	6,612,500	37,284,108	Jun 23 11:35 AM
Ramaswamy Vivek	10% Owner	Jun 18 '25	Sale	11.45	565,266	6,472,296	37,861,115	Jun 23 11:35 AM
Ramaswamy Vivek	10% Owner	Jun 20 '25	Proposed Sale	11.46	577,007	6,611,850		Jun 20 04:35 PM
Venker Eric	Officer	Jun 20 '25	Proposed Sale	11.45	100,000	1,145,268		Jun 20 04:13 PM
Ramaswamy Vivek	10% Owner	Jun 18 '25	Proposed Sale	11.45	565,266	6,472,996		Jun 18 04:38 PM
Ramaswamy Vivek	10% Owner	Jun 04 '25	Sale	11.34	547,430	6,207,856	38,627,181	Jun 06 05:49 PM
Ramaswamy Vivek	10% Owner	Jun 06 '25	Sale	11.19	200,800	2,246,952	38,426,381	Jun 06 05:49 PM
Ramaswamy Vivek	10% Owner	Jun 06 '25	Proposed Sale	11.19	200,800	2,246,311		Jun 06 04:33 PM
Venker Eric	President & COO	Jun 03 '25	Option Exercise	3.85	785,026	3,022,350	2,028,501	Jun 04 09:00 PM
Venker Eric	President & COO	Jun 02 '25	Option Exercise	3.85	600,000	2,310,000	1,677,197	Jun 04 09:00 PM
Venker Eric	President & COO	Jun 03 '25	Sale	11.22	566,278	6,353,639	1,462,223	Jun 04 09:00 PM
Venker Eric	President & COO	Jun 02 '25	Sale	11.07	433,722	4,801,303	1,243,475	Jun 04 09:00 PM
Ramaswamy Vivek	10% Owner	Jun 04 '25	Proposed Sale	11.34	547,430	6,208,008		Jun 04 04:42 PM
ERIC VENKER	Officer	Jun 03 '25	Proposed Sale	11.22	566,278	6,355,961		Jun 03 05:14 PM
ERIC VENKER	Officer	Jun 02 '25	Proposed Sale	11.07	433,722	4,803,341		Jun 02 04:16 PM
Venker Eric	President & COO	May 20 '25	Option Exercise	3.85	100,000	385,000	1,177,197	May 22 09:00 PM
Venker Eric	President & COO	May 20 '25	Sale	10.95	100,000	1,095,000	1,077,197	May 22 09:00 PM
Venker Eric	Officer	May 20 '25	Proposed Sale	10.95	100,000	1,094,986		May 20 04:30 PM
Ramaswamy Vivek	10% Owner	May 07 '25	Sale	11.18	625,000	6,987,500	39,174,611	May 08 08:51 PM
Ramaswamy Vivek	10% Owner	May 06 '25	Sale	11.47	273,959	3,142,310	39,799,611	May 08 08:51 PM
Ramaswamy Vivek	10% Owner	May 07 '25	Proposed Sale	11.18	625,000	6,987,388		May 07 04:37 PM
Ramaswamy Vivek	10% Owner	May 06 '25	Proposed Sale	11.47	273,959	3,143,287		May 06 04:21 PM
Venker Eric	President & COO	Apr 21 '25	Option Exercise	3.85	100,000	385,000	1,216,345	Apr 22 09:00 PM
Venker Eric	President & COO	Apr 21 '25	Sale	10.22	100,000	1,022,000	1,116,345	Apr 22 09:00 PM
Venker Eric	Officer	Apr 21 '25	Proposed Sale	10.22	100,000	1,022,374		Apr 21 03:22 PM
Venker Eric	President & COO	Mar 24 '25	Option Exercise	3.85	602,311	2,318,897	1,561,768	Mar 24 09:21 PM
Venker Eric	President & COO	Mar 20 '25	Option Exercise	3.85	400,000	1,540,000	1,274,979	Mar 24 09:21 PM
Venker Eric	President & COO	Mar 24 '25	Sale	10.82	434,478	4,701,052	1,127,290	Mar 24 09:21 PM
Venker Eric	President & COO	Mar 20 '25	Sale	11.06	315,522	3,489,673	959,457	Mar 24 09:21 PM
Venker Eric	Officer	Mar 20 '25	Proposed Sale	10.95	650,000	7,117,500		Mar 20 05:27 PM
Venker Eric	Officer	Mar 20 '25	Proposed Sale	11.11	100,000	1,110,537		Mar 20 03:54 PM
Venker Eric	President & COO	Feb 20 '25	Option Exercise	3.85	100,000	385,000	996,869	Feb 24 09:00 PM
Venker Eric	President & COO	Feb 20 '25	Sale	10.65	100,000	1,065,000	896,869	Feb 24 09:00 PM
Venker Eric	Officer	Feb 20 '25	Proposed Sale	10.65	100,000	1,065,022		Feb 20 03:35 PM
Kumar Rakhi	Chief Accounting Officer	Feb 13 '25	Option Exercise	3.85	187,500	721,875	390,764	Feb 18 09:00 PM
Kumar Rakhi	Chief Accounting Officer	Feb 13 '25	Sale	10.43	227,500	2,372,825	163,264	Feb 18 09:00 PM
Venker Eric	President & COO	Feb 12 '25	Option Exercise	3.85	300,000	1,155,000	1,032,294	Feb 14 09:00 PM
Venker Eric	President & COO	Feb 13 '25	Option Exercise	3.85	300,000	1,155,000	1,114,910	Feb 14 09:00 PM
Venker Eric	President & COO	Feb 12 '25	Sale	10.53	217,384	2,289,054	732,294	Feb 14 09:00 PM
Venker Eric	President & COO	Feb 13 '25	Sale	10.42	218,041	2,271,987	896,869	Feb 14 09:00 PM
Kumar Rakhi	Officer	Feb 13 '25	Proposed Sale	10.43	227,500	2,372,966		Feb 13 05:14 PM
Venker Eric	Officer	Feb 12 '25	Proposed Sale	10.50	600,000	6,300,000		Feb 12 05:29 PM
Venker Eric	President & COO	Jan 21 '25	Option Exercise	3.85	100,000	385,000	832,294	Jan 22 09:04 PM
Venker Eric	President & COO	Jan 21 '25	Sale	11.28	100,000	1,128,000	732,294	Jan 22 09:04 PM
Venker Eric	Officer	Jan 21 '25	Proposed Sale	11.28	100,000	1,128,457		Jan 21 04:30 PM
Roivant Sciences Ltd.	Director	Jan 13 '25	Buy	20.00	16,845,010	336,900,200	96,650,341	Jan 15 04:36 PM
Venker Eric	President & COO	Dec 27 '24	Option Exercise	3.85	250,000	962,500	845,580	Dec 31 09:00 PM
Venker Eric	President & COO	Dec 30 '24	Option Exercise	3.85	250,000	962,500	918,680	Dec 31 09:00 PM
Venker Eric	President & COO	Dec 27 '24	Sale	11.82	176,900	2,090,958	668,680	Dec 31 09:00 PM
Venker Eric	President & COO	Dec 30 '24	Sale	11.54	177,704	2,050,704	740,976	Dec 31 09:00 PM
Venker Eric	Officer	Dec 27 '24	Proposed Sale	11.75	360,000	4,230,000		Dec 27 04:54 PM
Sukhatme Mayukh	Pres&Chief Investment Officer	Dec 26 '24	Option Exercise	3.85	689,495	2,654,556	19,526,042	Dec 26 09:00 PM
Sukhatme Mayukh	Pres&Chief Investment Officer	Dec 24 '24	Option Exercise	3.85	185,946	715,892	19,022,493	Dec 26 09:00 PM
Sukhatme Mayukh	Pres&Chief Investment Officer	Dec 23 '24	Option Exercise	3.85	10,796	41,565	18,847,343	Dec 26 09:00 PM
Sukhatme Mayukh	Pres&Chief Investment Officer	Dec 26 '24	Sale	12.01	689,495	8,280,835	18,836,547	Dec 26 09:00 PM
Sukhatme Mayukh	Pres&Chief Investment Officer	Dec 24 '24	Sale	12.00	185,946	2,231,352	18,836,547	Dec 26 09:00 PM
Sukhatme Mayukh	Pres&Chief Investment Officer	Dec 23 '24	Sale	12.00	10,796	129,552	18,836,547	Dec 26 09:00 PM
Venker Eric	President & COO	Dec 20 '24	Option Exercise	3.85	100,000	385,000	695,580	Dec 26 09:00 PM
Venker Eric	President & COO	Dec 20 '24	Sale	11.49	100,000	1,149,000	595,580	Dec 26 09:00 PM
Sukhatme Mayukh	Officer	Dec 26 '24	Proposed Sale	12.01	689,495	8,277,401		Dec 26 04:14 PM
Sukhatme Mayukh	Officer	Dec 24 '24	Proposed Sale	12.00	185,946	2,231,700		Dec 26 08:02 AM
Sukhatme Mayukh	Officer	Dec 23 '24	Proposed Sale	12.00	10,796	129,555		Dec 23 04:21 PM
Sukhatme Mayukh	Pres&Chief Investment Officer	Dec 18 '24	Option Exercise	3.85	412,584	1,588,448	19,249,131	Dec 20 09:00 PM
Sukhatme Mayukh	Pres&Chief Investment Officer	Dec 18 '24	Sale	12.05	412,584	4,971,637	18,836,547	Dec 20 09:00 PM
Venker Eric	Officer	Nov 20 '24	Proposed Sale	11.49	100,000	1,148,554		Dec 20 04:29 PM
Sukhatme Mayukh	Officer	Dec 18 '24	Proposed Sale	12.05	412,584	4,969,631		Dec 18 04:33 PM
Venker Eric	President & COO	Nov 20 '24	Option Exercise	3.85	100,000	385,000	706,525	Nov 22 09:00 PM
Venker Eric	President & COO	Nov 20 '24	Sale	11.32	100,000	1,132,000	606,525	Nov 22 09:00 PM
Venker Eric	Officer	Nov 20 '24	Proposed Sale	11.32	100,000	1,132,008		Nov 20 04:45 PM
Venker Eric	President & COO	Oct 21 '24	Option Exercise	3.85	100,000	385,000	717,470	Oct 22 09:00 PM
Venker Eric	President & COO	Oct 21 '24	Sale	11.65	100,000	1,165,000	617,470	Oct 22 09:00 PM
Venker Eric	Officer	Oct 21 '24	Proposed Sale	11.65	100,000	1,165,393		Oct 21 04:45 PM
QVT Financial LP	Director by Deputization	Sep 26 '24	Sale	11.82	876,000	10,354,320	22,179,358	Sep 26 09:22 PM
QVT Financial LP	Director by Deputization	Sep 25 '24	Sale	11.77	50,000	588,500	23,055,358	Sep 26 09:22 PM
MANCHESTER KEITH S	Director	Sep 24 '24	Sale	11.62	368,052	4,278,604	1,412,126	Sep 26 08:35 PM
MANCHESTER KEITH S	Director	Sep 25 '24	Sale	11.77	134,948	1,587,704	1,277,178	Sep 26 08:35 PM
Gold Daniel Allen	Director	Sep 24 '24	Sale	11.62	1,565,670	18,200,914	5,723,423	Sep 26 08:34 PM
Gold Daniel Allen	Director	Sep 25 '24	Sale	11.77	991,593	11,666,389	4,731,830	Sep 26 08:34 PM
Gold Daniel Allen	Director	Sep 26 '24	Sale	11.82	876,000	10,354,320	22,179,358	Sep 26 08:34 PM
Gold Daniel Allen	Director	Sep 24 '24	Sale	11.62	577,186	6,709,787	2,079,059	Sep 26 08:34 PM
Gold Daniel Allen	Director	Sep 25 '24	Sale	11.77	415,551	4,889,317	1,713,508	Sep 26 08:34 PM
BNEI ZAHAV LLC	Director	Sep 25 '24	Proposed Sale	11.76	23,917	281,264		Sep 25 04:30 PM
RIOJA DOLCE LLC	Director	Sep 25 '24	Proposed Sale	11.76	170,817	2,008,808		Sep 25 04:25 PM
KEITH S MANCHESTER REVOCABLE T	Director	Sep 25 '24	Proposed Sale	11.76	134,948	1,586,988		Sep 25 04:23 PM
RIOJA LIETO LLC	Director	Sep 25 '24	Proposed Sale	11.76	170,817	2,008,808		Sep 25 04:20 PM
DANIEL GOLD & LAURA GOLD	Director	Sep 25 '24	Proposed Sale	11.76	991,593	11,661,134		Sep 25 04:19 PM
Gline Matthew	CEO	Sep 23 '24	Option Exercise	3.85	1,550,000	5,967,500	19,853,800	Sep 24 09:01 PM
Gline Matthew	CEO	Sep 23 '24	Sale	11.79	1,983,257	23,382,600	17,870,543	Sep 24 09:01 PM
Kumar Rakhi	Chief Accounting Officer	Sep 23 '24	Option Exercise	3.85	250,000	962,500	459,322	Sep 24 09:01 PM

MP MP Materials Corporation daily Stock Chart

Peers: REE

| Held by: IJR VTI VB XME VBK VXF SPSM REMX IJS SCHA

Index	-	P/E	-	EPS (ttm)	-0.62	Insider Own	26.71%	Shs Outstand	163.47M	Perf Week	7.00%
Market Cap	11.83B	Forward P/E	79.28	EPS next Y	0.84	Insider Trans	-4.54%	Shs Float	129.83M	Perf Month	-7.48%
Enterprise Value	12.00B	PEG	-	EPS next Q	-0.16	Inst Own	68.92%	Short Float	17.90%	Perf Quarter	88.30%
Income	-101.38M	P/S	48.87	EPS this Y	23.81%	Inst Trans	5.47%	Short Ratio	1.55	Perf Half Y	149.01%
Sales	242.12M	P/B	10.81	EPS next Y	351.38%	ROA	-4.31%	Short Interest	23.24M	Perf YTD	328.27%
Book/sh	6.18	P/C	15.68	EPS next 5Y	-	ROE	-9.57%	52W High	82.50 -19.02%	Perf Year	384.13%
Cash/sh	4.26	P/FCF	-	EPS past 3/5Y	- -41.29%	ROIC	-5.45%	52W Low	13.45 396.73%	Perf 3Y	102.09%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-15.00% 22.66%	Gross Margin	-23.66%	Volatility	4.42% 5.24%	Perf 5Y	376.53%
Dividend TTM	-	EV/Sales	49.55	EPS Y/Y TTM	-172.40%	Oper. Margin	-59.08%	ATR (14)	3.66	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.12	Sales Y/Y TTM	39.42%	Profit Margin	-41.87%	RSI (14)	53.51	Recom	1.85
Dividend Gr. 3/5Y	- -	Current Ratio	3.60	EPS Q/Q	8.54%	SMA20	-0.03%	Beta	2.34	Target Price	77.00
Payout	-	Debt/Eq	0.91	Sales Q/Q	83.61%	SMA50	3.65%	Rel Volume	0.74	Prev Close	65.98
Employees	804	LT Debt/Eq	0.84	Earnings	Aug 07 AMC	SMA200	96.89%	Avg Volume	15.01M	Price	66.81
IPO	Jun 22, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	34.01% 24.39%	Trades		Volume	11,180,467	Change	1.26%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-01-25	Upgrade	Jefferies	Hold → Buy	$80
Jul-31-25	Resumed	Morgan Stanley	Equal-Weight	$65
Jul-07-25	Downgrade	Jefferies	Buy → Hold	$33
Jun-05-25	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$34
Sep-27-24	Reiterated	Robert W. Baird	Outperform	$20 → $25
Jul-15-24	Initiated	BMO Capital Markets	Market Perform	$16.50
Apr-23-24	Downgrade	JP Morgan	Overweight → Neutral	$20 → $16
Mar-13-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$26 → $15.50
Sep-06-23	Upgrade	Northland Capital	Market Perform → Outperform
Aug-31-23	Initiated	JP Morgan	Overweight	$27
Apr-18-23	Downgrade	Northland Capital	Outperform → Market Perform	$32
Jul-13-22	Initiated	Canaccord Genuity	Buy	$44
Jun-06-22	Resumed	Northland Capital	Outperform	$60
Jun-01-22	Initiated	BMO Capital Markets	Outperform	$50
Feb-09-22	Upgrade	The Benchmark Company	Hold → Buy	$47
Nov-30-21	Resumed	BofA Securities	Buy	$52
Nov-11-21	Initiated	The Benchmark Company	Hold
Nov-11-21	Initiated	Jefferies	Buy	$55
Jul-23-21	Initiated	DA Davidson	Buy	$45
Jun-30-21	Initiated	Robert W. Baird	Outperform	$45

Show Previous Ratings

Today 06:11PM	Dow Jones Futures Rise After Fed Rate Cut, Nvidia Skids; Meta's Zuckerberg On Tap (Investor's Business Daily)
04:33PM	The Side of Rate Cuts Nobody Is Telling You About (MarketBeat)
01:41PM	IBD Stock Of The Day, Up 330%, Set To Join S&P MidCap 400 (Investor's Business Daily)
Sep-16-25 12:23PM	The U.S. Has a Powerful Tool to Fix Its Critical Mineral Problem (Barrons.com)
11:41AM	MP Materials Races Ahead in U.S. Magnet Manufacturing: Can It Deliver? (Zacks)
05:24AM	Loading…
05:24AM	Companies are lining up for U.S. government investment, says banker on MP Materials deal (MarketWatch)
Sep-15-25 09:40AM	Are Basic Materials Stocks Lagging Gold Fields Limited (GFI) This Year? (Zacks)
Sep-12-25 10:32AM	Locksley expands Mojave minerals footprint in California (Mining Technology)
03:05AM	Could Buying MP Materials Stock Today Set You Up for Life? (Motley Fool)
01:30AM	How the U.S. Will Break China's Rare Earth Dominance-and How to Play It (Barrons.com)
Sep-11-25 08:53PM	Lightning Round: Canadian National is way too cheap, says Jim Cramer (CNBC TV)
03:32AM	Morgan Stanley Maintains Hold Rating on MP Materials (MP) Stock (Insider Monkey)
Sep-10-25 12:54PM	Is MP Stock a Buy, Hold, or Sell After Its 146.3% Three-Month Rally? (Zacks)
Sep-07-25 08:27PM	AppLovin, Robinhood To Join S&P 500. The Stocks Are Jumping. (Investor's Business Daily)
10:08AM	DA Davidson Sticks With Buy on MP Materials (MP) on DoD Deal (Insider Monkey)
12:32PM	Loading…
Sep-06-25 12:32PM	New to Growth Stocks? Here's 1 Every Investor Should Have on Their Radar. (Motley Fool)
Sep-05-25 06:34PM	AppLovin, Robinhood Markets and Emcor Group Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600 (PR Newswire)
Sep-04-25 11:33AM	Can MP Materials Sustain Its Explosive NdPr Growth Momentum Ahead? (Zacks)
07:15AM	Should You Buy MP Materials Corp Stock Right Now? (Motley Fool)
Sep-02-25 02:02PM	The White House Premium: How Washington Is Creating AI Stock Rockets (InvestorPlace) -5.38%
12:00PM	Are You Looking for a Top Momentum Pick? Why MP Materials Corp. (MP) is a Great Choice (Zacks)
10:40AM	3 Heavily Shorted Stocks That Could Prove the Bears Wrong (MarketBeat)
Aug-30-25 07:42AM	The White House wants government stakes in more companies. The nuclear energy industry could be next. (Yahoo Finance)
Aug-28-25 04:05PM	MP Materials to Participate in Jefferies Industrials Conference (Business Wire)
08:00AM	Could Buying MP Materials Today Set You Up for Life? (Motley Fool)
07:06AM	Canada teams up with allies to consider financing critical mineral projects (Mining Technology)
04:05AM	The Smartest Mining Stocks to Buy With $100 Right Now (Motley Fool)
Aug-27-25 01:02PM	Can UUUU and Vulcan Elements Strengthen U.S. Rare Earth Magnet Supply? (Zacks)
12:59PM	Most Sovereign Wealth Funds Are Poor Performers. The U.S. May Still Get One. (Barrons.com)
12:52PM	MP vs. IDR: Which Rare Earth Stock is the Smarter Buy Now? (Zacks)
07:31AM	Loading…
07:31AM	MP Materials: How One Move Redefined the U.S. Magnet Supply Chain (MarketBeat)
12:02AM	Trump administration is investing in US rare earths in a push to break China's grip (Associated Press Finance)
Aug-26-25 07:51PM	State-Run Investment Funds Don't Tend to Perform Well Even as Trump Creates One (Barrons.com)
04:40PM	Trump Hints at U.S. Trade Leverage Over China as Rare Earth Tensions Resurface (GuruFocus.com)
02:28PM	Canada and allies to explore funding critical mineral projects, minister says (Reuters)
09:40AM	Is DRDGOLD Limited (DRD) Stock Outpacing Its Basic Materials Peers This Year? (Zacks)
09:34AM	US could seek piece of defense companies, Commerce chief says (Reuters)
08:12AM	Rare earth prices hit two-year peak after MP Materials stops China shipments (Reuters)
Aug-25-25 10:43PM	Trump Says US Has Much Bigger Leverage Over China on Magnets (Bloomberg) +6.53%
07:02PM	Trumps Intel Move Is Just the Beginning. Why a Sovereign Wealth Fund Is a Very Bad Idea. (Barrons.com)
07:02PM	The U.S. Has Created a Stealth Sovereign Wealth Fund. What Comes Next After Intel. (Barrons.com)
10:30AM	BC-Most Active Stocks (Associated Press Finance)
Aug-23-25 09:35AM	Is MP Materials Overvalued After Its 450% Surge? (Motley Fool)
Aug-22-25 04:55PM	Trump Team Mulls $2 Billion Shift From Chips To Minerals (GuruFocus.com) +6.53%
01:35PM	Trump says Intel has agreed to deal for US to take 10% equity stake (Reuters)
01:35PM	Trump says Intel has agreed to a deal for US to take 10% equity stake (Reuters)
12:50PM	Why Energy Fuels Stock Is Powering Higher Today (Motley Fool)
03:44AM	China's imports of US rare earth ore surge in July (Reuters)
Aug-21-25 03:09PM	Trump weighs using $2 billion in CHIPS Act funding for critical minerals, sources say (Reuters)
01:31PM	From Defense to Dollars: The Government's Play to Rebuild the Domestic Rare Earths Supply Chain (Benzinga)
12:15PM	UUUU Produces Dysprosium: Can It Redefine the U.S. REE Supply Chain? (Zacks)
Aug-19-25 01:13PM	Why Shares of USA Rare Earth Are Plunging Today (Motley Fool)
12:11PM	MP Materials Delivers Record Production Levels: Is It Sustainable? (Zacks)
09:53AM	Trump Targets Corporate America to Achieve Economic and Foreign Policy Goals (Bloomberg)
07:04AM	Intels CEO Draws Support for Revival From SoftBank, Trump (Bloomberg)
05:37AM	Vulcan Elements secures non-Chinese rare earth supply from ReElement (Mining Technology)
Aug-18-25 01:57PM	Trump Administration in Talks to Take a 10% Stake in Intel (Bloomberg)
12:38PM	Trump administration in talks to take 10% stake in Intel, Bloomberg News reports (Reuters)
10:30AM	BC-Most Active Stocks (Associated Press Finance)
Aug-15-25 03:52PM	Why Intel Stock Popped on Friday (Motley Fool)
08:00AM	Here Are My Top 2 Mining Stocks to Buy Now (Motley Fool)
03:34AM	Intel shares rise on report of possible US government stake (Reuters)
Aug-14-25 04:29PM	Trump, U.S. reportedly considering a stake in Intel, per Bloomberg (The Columbus Dispatch)
03:53PM	Trump weighs taking stake in Intel, Bloomberg News reports (Reuters)
07:15AM	Up 380% in 2025, Is It Too Late to Buy MP Materials Stock? (Barchart)
Aug-12-25 01:23PM	Should You Buy, Sell or Hold MP Stock Post Q2 Earnings Beat? (Zacks)
10:08AM	MP Materials Stock Is Falling on a Strange Downgrade (Barrons.com)
09:23AM	MP Materials Stock Rides Rare Earth Boom to New Highs (MarketBeat)
06:00AM	How deals with Apple and Trumps Pentagon turned rare earth miner MP Materials into a red-hot stock (Fortune)
Aug-11-25 07:09PM	Why MP Materials Stock Got Mashed on Monday (Motley Fool)
02:16PM	MP Materials Stock Falls On Strange Downgrade. Analyst Quadruples Price Target. (Barrons.com)
10:30AM	BC-Most Active Stocks (Associated Press Finance)
09:45AM	Antimony Mining Market Experiencing Rapid Growth as a Result of Growing Demand Across Various Sectors (PR Newswire)
Aug-08-25 03:01PM	Why MP Materials Stock Popped Friday (Motley Fool)
09:38AM	Stocks open higher after latest batch of earnings; gold prices jump (MarketWatch)
07:28AM	Here's Why MP Materials Stock Surged Again This Week (Motley Fool)
06:04AM	MP Materials hits record high after smaller loss, Pentagon and Apple boost (Reuters)
05:24AM	Premarket movers: Expedia, MP Materials, Trade Desk, Microchip Technology (MarketWatch)
04:55AM	MP Materials Stock Soars Even Higher on Earnings. The Future Looks Bright, Too. (Barrons.com)
03:46AM	Stock Market Today: Dow, S&P 500 and Nasdaq open higher as gold prices jump (MarketWatch)
03:43AM	MP Materials Corp (MP) Q2 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ... (GuruFocus.com)
Aug-07-25 06:26PM	Mp Materials rallies after strong Q2 results, magnetic segment gains traction (Investing.com) +5.27%
06:25PM	MP Materials Corp. (MP) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
05:18PM	Dow Jones Futures: AppLovin, Robinhood Flash Buy Signals As Market Fades; MP Materials, Sezzle Earnings Late (Investor's Business Daily)
04:40PM	Stocks to Watch Recap: Eli Lilly, Firefly, DoorDash, TSMC (The Wall Street Journal)
04:32PM	MP Materials posts smaller loss as rare earths production surges (Reuters)
04:05PM	MP Materials Reports Second Quarter 2025 Results (Business Wire)
02:56PM	Trump Admin Supporting Mine-to-Magnet Supply Chain for Rare Earths (Bloomberg)
01:38PM	Stocks to Watch Thursday: Eli Lilly, Firefly, DoorDash, TSMC (The Wall Street Journal)
12:53PM	GM strikes deal with Noveon Magnetics for supply of rare earth magnets (Just Auto)
10:47AM	MP Materials Stock Is Rising Ahead of Earnings. How Things Can Get Even Better. (Barrons.com)
08:41AM	JPMorgan says Apple delivered masterclass in managing geopolitics (Investing.com)
05:53AM	Stocks to Watch Thursday: Apple, Corning, Duolingo (The Wall Street Journal)
Aug-06-25 10:18PM	Jim Cramer Believes MP Materials Report Will be "Positive" (Insider Monkey)
08:20PM	Stocks to Watch Afterhours: Apple, DraftKings, Corning, Airbnb (The Wall Street Journal)
12:00PM	MP Materials Corp. (MP) is a Great Momentum Stock: Should You Buy? (Zacks)
10:29AM	Why MP Materials Stock Surged an Incredible 85% in July (Motley Fool)
Aug-05-25 09:02PM	Corrections & Amplifications (The Wall Street Journal)
08:10PM	Ivanhoe Electric (IE) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
12:07PM	Should You Buy, Hold or Sell MP Materials Stock Ahead of Q2 Earnings? (Zacks)

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the Materials and Magnetics segments. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Rosenthal Michael Stuart	Chief Operating Officer	Aug 29 '25	Sale	72.02	150,000	10,802,838	1,284,409	Aug 29 09:23 PM
Rosenthal Michael Stuart	Officer	Aug 29 '25	Proposed Sale	72.02	150,000	10,803,255		Aug 29 04:20 PM
Hoops Elliot Dean	General Counsel and Secretary	Aug 01 '25	Sale	60.33	6,337	382,304	0	Aug 01 09:22 PM
Hoops Elliot Dean	Officer	Aug 01 '25	Proposed Sale	60.29	6,337	382,038		Aug 01 03:58 PM
Hoops Elliot Dean	General Counsel and Secretary	Jul 01 '25	Sale	31.94	6,338	202,464	6,337	Jul 03 09:27 PM
Hoops Elliot Dean	Officer	Jul 01 '25	Proposed Sale	31.90	6,338	202,209		Jul 01 04:36 PM
Hoops Elliot Dean	General Counsel and Secretary	Jun 26 '25	Sale	36.37	5,523	200,872	69,749	Jun 27 09:30 PM
Hoops Elliot Dean	Officer	Jun 26 '25	Proposed Sale	36.33	5,523	200,651		Jun 26 04:17 PM
Hoops Elliot Dean	General Counsel and Secretary	Jun 13 '25	Sale	29.96	5,538	165,918	12,675	Jun 13 09:25 PM
Hoops Elliot Dean	General Counsel and Secretary	Jun 12 '25	Sale	29.95	800	23,960	18,213	Jun 13 09:25 PM
Hoops Elliot Dean	Officer	Jun 13 '25	Proposed Sale	29.96	6,338	189,900		Jun 13 04:30 PM
Litinsky James H.	Chairman and CEO	Apr 14 '25	Sale	27.08	199,180	5,393,794	13,643,076	Apr 16 09:11 PM
Litinsky James H.	Chairman and CEO	Mar 25 '25	Sale	27.03	396,293	10,711,800	13,860,775	Mar 27 09:40 PM
Litinsky James H.	Chairman and CEO	Mar 26 '25	Sale	27.00	18,519	500,013	13,842,256	Mar 27 09:40 PM
Litinsky James H.	Chairman and CEO	Mar 20 '25	Sale	27.04	95,621	2,585,592	14,257,068	Mar 21 09:15 PM
Litinsky James H.	Chairman and CEO	Mar 18 '25	Sale	26.71	639,294	17,075,543	14,513,864	Mar 19 09:18 PM
Litinsky James H.	Chairman and CEO	Mar 17 '25	Sale	26.77	489,918	13,115,105	15,153,158	Mar 19 09:18 PM
Litinsky James H.	Chairman and CEO	Mar 19 '25	Sale	26.94	161,175	4,342,054	14,352,689	Mar 19 09:18 PM
JAMES HENRY LITINSKY REVOCABLE	Director	Mar 19 '25	Proposed Sale	26.83	788,356	21,151,591		Mar 19 05:04 PM
Corbett Ryan	Chief Financial Officer	Mar 14 '25	Sale	25.51	60,000	1,530,391	230,100	Mar 18 06:45 PM
Corbett Ryan	Chief Financial Officer	Mar 17 '25	Sale	27.00	15,000	405,000	214,812	Mar 18 06:45 PM
JAMES HENRY LITINSKY REVOCABLE	Director	Mar 18 '25	Proposed Sale	26.69	721,726	19,262,867		Mar 18 05:06 PM
JAMES HENRY LITINSKY REVOCABLE	Director	Mar 17 '25	Proposed Sale	26.83	489,918	13,144,500		Mar 17 05:05 PM
Corbett Ryan	Officer	Mar 17 '25	Proposed Sale	27.00	15,000	405,000		Mar 17 04:03 PM
Corbett Ryan	Officer	Mar 14 '25	Proposed Sale	25.00	60,000	1,500,000		Mar 14 04:09 PM
Litinsky James H.	Chairman and CEO	Feb 04 '25	Sale	24.01	386,223	9,273,214	15,643,076	Feb 06 09:13 PM
Litinsky James H.	Chairman and CEO	Dec 03 '24	Sale	23.39	1,579,110	36,934,246	16,029,299	Dec 04 07:37 PM
Litinsky James H.	Chairman and CEO	Dec 02 '24	Sale	20.68	234,667	4,852,914	17,608,409	Dec 04 07:37 PM
JAMES HENRY LITINSKY REVOCABLE	Director	Dec 03 '24	Proposed Sale	20.81	1,200,000	24,972,000		Dec 03 05:01 PM
Litinsky James H.	Chairman and CEO	Nov 26 '24	Sale	20.22	300,000	6,066,000	18,043,076	Nov 29 07:11 PM
Litinsky James H.	Chairman and CEO	Nov 27 '24	Sale	20.90	200,000	4,180,000	17,843,076	Nov 29 07:11 PM
Corbett Ryan	Chief Financial Officer	Nov 29 '24	Sale	21.50	35,000	752,500	260,021	Nov 29 07:00 PM
JAMES HENRY LITINSKY REVOCABLE	Director	Nov 29 '24	Proposed Sale	20.84	1,000,000	20,840,000		Nov 29 01:54 PM
Corbett Ryan	Officer	Nov 29 '24	Proposed Sale	21.50	35,000	752,500		Nov 29 01:12 PM
JAMES HENRY LITINSKY REVOCABLE	Officer	Nov 27 '24	Proposed Sale	20.90	200,000	4,180,420		Nov 27 04:22 PM
JAMES HENRY LITINSKY REVOCABLE	Officer	Nov 26 '24	Proposed Sale	20.22	300,000	6,064,680		Nov 26 04:41 PM
Litinsky James H.	Chairman and CEO	Nov 18 '24	Sale	18.45	300,000	5,535,000	18,221,776	Nov 18 09:35 PM
Corbett Ryan	Chief Financial Officer	Nov 18 '24	Sale	18.30	15,195	278,068	295,021	Nov 18 09:28 PM
Hoops Elliot Dean	General Counsel and Secretary	Nov 15 '24	Sale	18.03	30,000	540,900	8,114	Nov 18 09:23 PM
JAMES HENRY LITINSKY REVOCABLE	Officer	Nov 18 '24	Proposed Sale	18.45	300,000	5,534,760		Nov 18 04:19 PM
Ryan S Corbett	Officer	Nov 18 '24	Proposed Sale	18.29	15,195	277,923		Nov 18 02:13 PM
HOOPS FAMILY TRUST	Officer	Nov 15 '24	Proposed Sale	18.03	30,000	540,921		Nov 15 04:56 PM

ROIV

Roivant Sciences Ltd

MP

MP Materials Corporation

Upgrade your FINVIZ experience